Is NCT03293992 results overdue?

Yes — results are overdue. Primary completion was 2017-12-15; the FDAAA-801 reporting deadline (2018-12-15) passed 2745 days ago and no results are posted on ClinicalTrials.gov.

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT ID	NCT03293992 ↗
Sponsor	Hoffmann-La Roche (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2017-12-15 (ACTUAL)
Reporting deadline	2018-12-15 (completion + 365d)
Days overdue	2745
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `eae7fd792be8d009…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03293992. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.